Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Amplia Therapeutics Ltd. (INNMF) had Weighted-Average Shares Outstanding (Diluted) of 469.65M for the most recently reported fiscal year, ending 2026-03-31.
| Income Statement Financials | |
$3.63M |
|
$-5.10M |
|
-- |
|
$3.63M |
|
$8.72M |
|
$-5.09M |
|
$-0.01M |
|
$-5.10M |
|
$-5.10M |
|
$-5.10M |
|
$-5.10M |
|
$-5.10M |
|
$-5.10M |
|
$-5.09M |
|
$-5.03M |
|
469.65M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
469.65M |
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$21.86M |
|
$0.02M |
|
$5.56M |
|
$27.42M |
|
$1.11M |
|
$0.17M |
|
$0.20M |
|
$1.30M |
|
$26.11M |
|
$20.86M |
|
$26.11M |
|
513.07M |
|
| Cash Flow Statement Financials | |
$-5.78M |
|
$-0.06M |
|
$17.16M |
|
$7.19M |
|
$18.43M |
|
$11.24M |
|
$0.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
19.78 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
100.00% |
|
-140.09% |
|
-140.09% |
|
-138.41% |
|
-140.40% |
|
-140.40% |
|
$-5.80M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
-- |
|
1.15 |
|
317.72 |
|
-19.53% |
|
-24.44% |
|
-18.60% |
|
-19.40% |
|
$0.05 |
|
$-0.01 |
|
$-0.01 |
|